Hospital Universitario Vall d'Hebron

Barcelona, Other 08035

0 studies enrolling now · 2 studies all time

What they study most

Fallopian Tube Cancer, Metastatic Colorectal Adenocarcinoma, Ovarian Cancer, Peritoneal Cancer

Studies at this site

• Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer — Completed
• A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) — Completed